OLGA COBOZEVA: Open Payments
NPI 1164821864 · N CHELMSFORD, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$212 in 10 payments from 6 companies in 2025. Trend: 2023 $1,036 · 2024 $671 · 2025 $212
Food & beverage: $212
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $79 |
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $32 |
| E.R. Squibb & Sons, L.L.C. | 1 | $25 |
| Lundbeck LLC | 1 | $24 |
| ABBVIE INC. | 1 | $17 |
Products named: CAPLYTA, REXULTI, TRINTELLIX, VRAYLAR.
Industry payments across MA — which companies pay providers there.
